Pfizer, Inc. (PFE) Reports In-Line Q3 EPS; Announces $10B Buyback Plan

November 1, 2012 7:05 AM

Pfizer, Inc. (NYSE: PFE) reported Q3 EPS of $0.53, in-line with the analyst estimate of $0.53. Revenue ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found